SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 6,102 | 6,096 | 3,796 | 1,638 | 2,063 |
| Cost of Goods | 1,785 | 1,773 | 1,079 | 354 | 605 |
| Gross Profit | 4,317 | 4,323 | 2,717 | 1,284 | 1,458 |
| Operating Expenses | 20,958 | 20,353 | 17,635 | 15,384 | 13,617 |
| Operating Income | -15,856 | -15,257 | -14,839 | -13,746 | -11,554 |
| Interest Expense | 2,101 | 2,092 | 2,060 | 2,010 | 1,961 |
| Other Income | 3,849 | 3,537 | 1,265 | 1,602 | 2,305 |
| Pre-tax Income | -14,108 | -13,812 | -15,634 | -14,154 | -11,210 |
| Net Income Continuous | -14,108 | -13,812 | -15,634 | -14,154 | -11,210 |
| Net Income | $-14,108 | $-13,812 | $-15,634 | $-14,154 | $-11,210 |
| EPS Basic Total Ops | -0.36 | -0.35 | -0.41 | -0.36 | -0.30 |
| EPS Basic Continuous Ops | -0.36 | -0.36 | -0.40 | -0.37 | -0.30 |
| EPS Diluted Total Ops | -0.36 | -0.35 | -0.41 | -0.36 | -0.30 |
| EPS Diluted Continuous Ops | -0.36 | -0.36 | -0.40 | -0.37 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.36 | -0.35 | -0.41 | N/A | N/A |
| EBITDA(a) | $-15,805 | $-15,251 | $-15,035 | $-13,637 | $-11,449 |